Ulisse Biomed Spa
MIL:UBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
US |
|
VRX Silica Ltd
ASX:VRX
|
AU |
|
P
|
PLS Plantations Bhd
KLSE:PLS
|
MY |
|
PSC Corporation Ltd
SGX:DM0
|
SG |
|
Chill Brands Group PLC
LSE:CHLL
|
UK |
|
V
|
Victorian Plumbing Group PLC
LSE:VIC
|
UK |
|
Allstate Corp
NYSE:ALL
|
US |
|
BJ's Wholesale Club Holdings Inc
NYSE:BJ
|
US |
|
Intuit Inc
NASDAQ:INTU
|
US |
|
S
|
Satis Group SA
WSE:STS
|
PL |
|
XRF Scientific Ltd
ASX:XRF
|
AU |
|
Container Corporation of India Ltd
NSE:CONCOR
|
IN |
|
W
|
Watt's SA
SGO:WATTS
|
CL |
Wall Street
Price Targets
UBM Price Targets Summary
Ulisse Biomed Spa
According to Wall Street analysts, the average 1-year price target for
UBM
is 1.52 EUR
with a low forecast of 1.5 EUR and a high forecast of 1.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is UBM's stock price target?
Price Target
1.52
EUR
According to Wall Street analysts, the average 1-year price target for
UBM
is 1.52 EUR
with a low forecast of 1.5 EUR and a high forecast of 1.56 EUR.
What is Ulisse Biomed Spa's Revenue forecast?
Projected CAGR
87%
For the last 5 years the
compound annual growth rate for
Ulisse Biomed Spa's revenue is
135%.
The projected
CAGR
for the next 3 years is
87%.
